fbpx
Knowledge is the first and last step to investing

Biocon signs licensing & supply agreement with Brazil-based Biomm for commercialisation of Semaglutide.

Recommended For You

Next Post
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?